David M Markovitz

Title: The Innovative Contributions of David M Markovitz

Introduction

David M Markovitz is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of biomedical research, particularly in the development of chimeric antigen receptors (CAR) for cancer treatment. With a total of 10 patents to his name, Markovitz continues to push the boundaries of innovation in medical science.

Latest Patents

One of his latest patents focuses on chimeric antigen receptors targeting abnormal glycobiology. The disclosure provides a CAR polypeptide that includes an antigen binding domain with an extracellular lectin, which specifically binds to glycoproteins expressed on the surface of target cells. This invention also includes engineered lymphocytes that express the CAR polypeptide, a nucleic acid molecule encoding the CAR polypeptide, and methods for treating cancer.

Career Highlights

Markovitz is affiliated with the University of Michigan, where he conducts his research and development work. His innovative approaches have garnered attention in the scientific community, leading to advancements in cancer therapies.

Collaborations

Some of his notable coworkers include Nirit Mor-Vaknin and Challice L Bonifant. Their collaborative efforts contribute to the ongoing research and development in the field of immunotherapy.

Conclusion

David M Markovitz's work exemplifies the spirit of innovation in the medical field. His contributions, particularly in the area of chimeric antigen receptors, hold promise for future cancer treatments.